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1 
INTRODUCTION 
Recent reports concerning the etiology of bovine viral diarrhea-
mucosal disease complex have shown that two forms of bovine viral diarrhea 
virus are required for the manifestation of mucosal disease (MD). Mucosal 
disease is seen only when calves persistently infected with noncytopathic 
BVDV are superinfected with cytopathic BVDV. Involvement of two forms of 
BVDV in the manifestation of MD strongly indicate that distinct differ-
ences exist between cytopathic and noncytopathic isolates of BVDV. Stud-
ies employing serological and immunological methods have not shown dis-
tinct differences between these two forms. Limited attention has been 
given to the possibility that these differences may exist at a structural 
level. 
The literature which deals with dissociated polypeptides of BVDV has 
been generally limited to cytopathic isolates. One report has been made 
as to the dissociated polypeptides present in a noncytopathic isolate and 
possible distinctions between it and other cytopathic isolates (Akkina 
1982). Further studies are required to determine if a significant differ-
ence in structural polypeptides exists between these two types of BVDV. 
To determine if significant differences between cytopathic and non-
cytopathic BVDV are present at the structural level, the various isolates 
to be compared must be purified. This has not been an easy task with 
BVDV, since many of ·the standard virus purification methods fail to yield 
high levels of infectivity for BVDV. Reduced levels of infectivity re-
covered for BVDV using physical methods of purification can be attributed 
2 
to disruption of the BVD viral envelope. In an effort to overcome this 
obstacle, a gentler method of purification was required. 
A method was proposed by Kristiansen et al. (1979) for purification 
of BVDV using affinity chromatography to preserve the viral envelope. 
Several lectins were used in association with affinity chromatography for 
the purification of BVDV. These include concanavalin A, Lens culinaris, 
and Vicia ervilia lectins with an affinity for mannose and N-acetyl-
glucosamine, and Crotalaria juncea lectin with an affinity for galactose. 
The V. ervilia and C. juncea lectins proved to be effective in the puri-
fication of BVDV, but neither of these lectins was readily available. 
Shortly after these findings were published, another lectin, Ricinus 
communis agglutinin was found to be effective in the purification by af-
finity chromatography of hog cholera virus (Neukirch et al. 1981). Like 
f· juncea lectin, B_. communis agglutinin has an affinity for galactose. 
Hog cholera virus and BVDV are both members of the genus Pestivirus with-
in the family Togaviridae and are known to share similar antigens as 
measured by serological methods. Because of these similarities and the 
similarity of the two lectins, affinity chromatography with the lectin R. 
communis agglutinin was used in this study for the purification of BVDV. 
The dissociated polypeptides of six purified isolates of BVDV were 
separated and compared by three methods, high performance gel permeation 
chromatography under nondenaturing and denaturing conditions, continuous 
and discontinuous sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS-PAGE), and Western blotting with subsequent labeling of the 
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polypeptides with specific immunoglobulins. By using these methods, 
specific distinctions which may exist between three cytopathic isolates, 
Singer, NADL, and TGAC; and three noncytopathic isolates, 7443, NY-1, and 
Tifton were studied. 
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LITERATURE REVIEW 
History of BVD-MD 
The bovine viral diarrhea-mucosal disease (BVD-MD) complex was first 
described in 1946 as separate disease entities. These entities presented 
very similar clinical pictures in that infected cattle had severe diar-
rhea, ulcerations of the oral mucosa, leukopenia, anorexia, severe lacri-
mation, and a mucopurulent nasal discharge (Childs 1946, Olafson et al. 
1946, Ramsey and Chivers 1953). The major distinctions between these two 
entities were the mortality and morbidity rates. 
Olafson et al. (1946) studied a disease in the New York area which 
often affected nearly 803 of a herd, but with a mortality rate of 43 to 
83. Upon necropsy of affected animals, ulcerations were observed on the 
oral mucosa, muzzle, nares, pharynx, larynx, esophagus, and cecum. Hemor-
rhages were observed on the omasum, subcutaneous tissue, epicardium, and 
the vaginal mucosa. The lesions observed were often less severe than the 
clinical signs would indicate. Abortions were also characteristic of this 
disease entity, occurring 10 days to 3 months after the initial outbreak. 
The other element of this complex was first identified in Saskatchewan 
as X-disease of cattle by Childs (1946). Several years later, Ramsey and 
Chivers (1953) described mucosal disease (MD) in Iowa cattle, a disease 
similar to Childs' X-disease of cattle. Mucosal disease, as described by 
Ramsey and Chivers (1953) had a morbidity rate which ranged from 53 to 
203 and a mortality rate which was often greater than 903. Necropsy of 
these animals revealed that erosions were present in the buccal, pharyn-
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geal and oral cavities, on the tongue and gingivae. Severe erosions could 
be seen on the esophageal epithelium and in the abomasum, stomach, over 
the Payer's patches, and scattered throughout the small and large intes-
tines. The lesions on the distal 2 to 3 feet of the large intestine 
would advance to such a degree that the mucosal surface was often en-
tirely absent. Hemorrhages could be seen in the subepicardium and/or 
subendocardium. There was a conspicuous absence of leukocyte infiltra-
tion. Lymph nodes were only slightly edematous and rarely showed any 
significant enlargement or other lesions. Another feature of MD was the 
often occurring ulcerative skin lesions. These were seen near the oral 
labia, inside the ears, medial sides of arms and thighs, and perineal 
region (Ramsey 1956, Pritchard 1963). Lameness, which was also fre-
quently present, was the result of interdigital necrosis and disfigura-
tion of the coronary region (Pritchard 1963). 
Another disease at this time had also been identified as X-disease. 
This second X-disease, or hyperkeratosis, had clinical signs similar to 
those of the BVD-MD complex, but especially to MD. The one feature which 
distinguished hyperkeratosis from BVD and MD was the thickened, dry, wrin-
kled skin of the affected animals (Olafson 1947). 
Attempts to transmit BVD and MD to other susceptible cattle yielded 
yet another difference. Olafson et al. (1946) found that the milder dis-
ease, BVD, could easily be transmitted by drenching susceptible cattle 
with fecal material or by the injection of blood or splenic tissue emul-
sion. The clinical signs shown by these infected cattle were similar to 
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those seen in the field. However, transmission studies with MD often pro-
duced little more than a mild fever, failing to reproduce the clinical 
signs seen in the field (Ramsey and Chivers 1953, Pritchard 1963). These 
differences in experimentally produced infections led to speculation that 
these two diseases resulted from infection with the same virus, but re-
quired a secondary infection for the production of MD (Baker et al. 1954); 
or that separate infectious agents were involved (Ramsey artd Chivers 1953, 
Ramsey 1956). 
Before the agent, or a:gents, could be identified from both diseases, 
each had to be isolated. Olafson et al. (1946) had isolated the agent of 
the milder disease by inoculating susceptible cattle with various mate-
rials taken from an ill animal. Further efforts to identify this agent 
led Olafson and Rickard (1947) to conclude that the agent responsible was 
a virus. (At their suggestion, this disease is now referred to as bovine 
viral diarrhea (BVD).) Several isolates obtained from disease outbreaks 
identified as BVD were compared to the New York-1 (NY-1) isolate of BVD, 
first identified by Olafson et al. (1946), by cross-immunization studies 
and were found to be related (Baker et al. 1954, Pritchard et al. 1956, 
Gillespie and Baker 1959). 
In attempts to find a more convenient host for viral propagation, 
Olafson and Rickard (1947) inoculated rabbits, guinea pigs, sheep, and 10-
day-old chick embryos. None of these proved to be a suitable host for the 
BVD virus (BVDV). Other workers were also unsuccessful in finding an al-
ternate host which could manifest the clinical signs of BVD. However, 
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Baker et al. (1954) found that the virus could be propagated in rabbits; 
and when cattle were infected with the rabbit-passed virus, immunity to 
BVDV resulted. 
In 1957, Lee and Gillespie (1957) had successfully isolated the viral 
diarrhea virus in embryonic bovine kidney cell culture. The isolated 
virus proved to be noncytopathic in cell culture; consequently, inocula-
tion of cattle had to be used to show that the virus had been isolated. 
Underdahl et al. (1957) isolated two cytopathic viruses in embryonic 
bovine kidney cell culture from separate outbreaks of MD. Cross immuniza-
tion tests showed these two isolates to be immunologically related. The 
authors found neutralizing antibodies in several herds with no known his-
tory or clinical signs of MD. This evidence of widespread exposure of 
healthy animals to these isolates, and the failure to experimentally re-
produce MD as seen in the field cast doubt as to whether this virus was 
responsible for MD (Ramsey and Chivers 1953, Pritchard 1963). 
Gillespie et al. (1960) isolated a cytopathic virus from the spleen 
of a calf having clinical signs associated with BVD. This isolate, iden-
tified as Oregon C24V, was found to be related by cross-immunization to 
the noncytopathic isolates of BVDV. In further work, Gillespie et al. 
(1962) observed that noncytopathic BVDV infected cell cultures were re-
fractory to infection by cytopathic BVDV. Presence of noncytopathic BVDV 
in cell culture prevented the characteristic cytopathic effect of super-
infecting cytopathic BVDV from being demonstrated. Isolation and identi-
fication of a cytopathic form of BVDV and recognition of the interference 
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phenomenon provided researchers with a biological system in which work 
with BVDV did not require the continued need for cattle inoculations. 
New York-1, the first noncytopathic isolate identified as being BVDV, 
and Oregon C24V were found to be antigenically related on the basis of 
cross-neutralization tests (Kniazeff and Pritchard 1960). These compari-
sons were soon expanded to include additional cytopathic isolates which 
were obtained from both BVD and MD (Gillespie et al. 1961). Findings 
that this wide range of isolates were antigenically related resulted in 
the recognition of these diverging clinical conditions as forming the 
bovine viral diarrhea-mucosal disease complex. 
Clinical Syndrome 
Bovine viral diarrhea-mucosal disease complex is recognized today as 
three distinct clinical entities, bovine viral diarrhea, mucosal disease, 
and the persistently infected animal. Each of these presents its own 
characteristic set of clinical signs. 
Bovine viral diarrhea - acute infection 
The most prevalent syndrome of BVD is the acute infection which oc-
curs in cattle of all ages. Cattle undergoing an acute infection may 
demonstrate a variety of clinical signs; including transient fever, diar-
rhea, leukopenia, depression, anorexia, tachycardia, polypnea, nasal dis-
charge, dry nonproductive cough, dehydration and abortion. Erosions 
and/or reddened areas may be seen on the lips, dental pad, buccal mucosa, 
nares, muzzle and vulva. Lameness, as a result of laminitis, can also be 
a common clinical sign (Pritchard et al. 1956, Pritchard 1963). The 
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extent with which these lesions are present vary from animal to animal and 
from herd to herd. 
Serological evidence for the presence of viral neutralizing anti-
bodies suggests that most cattle have experienced a BVD viral infection 
(Pritchard 1963). In the majority of these cases, the animal had a sub-
clinical infection, evident only by a slight rise in body temperature, 
leukopenia, and mild transient diarrhea, and resulting in full recovery. 
Other cases of the acute infection were characterized by sudden onset of 
fever, depression, tachycardia, polypnea, anorexia, nasal discharge, non-
productive cough, iesions ·on the nasal and oral mucosa, and diarrhea per-
sisting continuously or intermittently for 1 day to 4 weeks (Pritchard 
1963). 
An acute respiratory form of BVD was seen in association with ship-
ping fever. Reggiardo (1979) reported the involvement of BVDV in severe 
pneumonia which was unresponsive to antibiotic therapy. From the lesions, 
BVDV and Pasteurella hemolytica type 1 were isolated. In contrast to 
other forms of BVD-MD, the typical gross lesions associated with BVD-MD 
were usually absent. In a few cases, microscopic lesions could be seen 
in the pharyngeal and esophageal mucosas. 
Another syndrome associated with BVD is the chronic infection gener-
ally occurring in animals 6 to 14 months of age, after the colostral anti-
body has declined. The onset of the clinical signs associated with the 
chronic infection are ill-defined. These animals may not grow at a rate 
comparable to age-mates; or they may become cachectic and experience in-
termittent or continuous diarrhea, or no diarrhea. Histological changes 
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which occur in chronic BVD are very similar to those seen in acute BVD. 
The course of this syndrome may vary from 2 to 6 months and usually re-
sults in total recovery (Pritchard 1963). 
Bovine viral diarrhea virus infection generally results in life long 
immunity, but only after the animal has experienced a brief period of im-
munosuppression, which has become the hallmark of the BVD-MD complex. 
Bovine viral diarrhea virus has a predilection for cells of the immune 
system. Leukopenia occurs during the time span between the two febrile 
responses, coinciding with peak viral titers in the blood stream 
(Pritchard 1963). In studies utilizing cattle infected with a cytopathic 
isolate, Bolin et al. (1985a) followed the fluctuating levels of leuko-
cytes during leukopenia. Total numbers of leukocytes were decreased from 
preexposure levels by approximately 35% on the fourth day after infection. 
The percentage of T lymphocytes was reduced from preexposure levels by 52% 
at this time. Although the percentage of B lymphocytes remained at pre-
exposure levels, the absolute number of B lymphocytes were reduced on the 
fourth day post infection. On the seventh day post infection, total num-
ber of leukocytes had returned to preexposure levels. At this time, ab-
solute numbers of T and B lymphocytes remained decreased, along with de-
creased percentages of monocytes, eosinophils and basophils and increased 
percentage of neutrophils. By 17 days post infection, all cell counts had 
returned to preexposure levels. Roth et al. (1981) reported similar re-
ductions in cell numbers of neutrophils, lymphocytes, and eosinophils 
following BVDV infection. 
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Lymphocytic depletion was also noted during gross and histological 
examination of BVD associated lesions. Gross observations of lymphatic 
tissues from cases of both BVD and MD appeared normal. Microscopically, 
partial to complete depletion of lymphocytes were seen in the lymph nodes, 
thymus and spleen. Necrotic foci were occasionally observed in the spleen 
and lymph nodes. Decreased or total lack of differentiation between the 
cortex and medulla was often seen in the thymus (Ramsey 1956, Carlson et 
al. 1957, Pritchard 1963). In conjunction with this, lymphocytic infil-
tration, normally associated with severe lesions in certain diseases, has 
been noted to be absent in some animals simultaneously infected with BVDV 
(Ramsey 1956). This failure of lymphocytic infiltration to occur may be 
associated with in vitro suppression of the chemotactic response, result-
ing from BVDV infection of monocytes (Ketelsen et al. 1979). 
Truitt and Shechmeister (1973) demonstrated the in vitro ability of 
BVDV to replicate' within nonimmune and immune leukocytes. A slower in-
crease in extracellular virus and lower titers were seen in macrophage 
cultures obtained from immune animals as compared to those from nonimmune 
animals. If BVDV antibody was included in these cultures, extracellular 
virus was not present; however, viral titers returned to previous levels 
when the antibody was removed. Leukocyte and lymphocyte enriched cultures 
obtained from nonimmune and immune animals behaved similarly, in that they 
produced comparable viral titers. 
A difference was observed when leukocyte and lymphocyte enriched cul-
tures were stimulated with phytohemagglutinin (PHA). Phytohemagglutinin 
stimulated nonimmune leukocyte and lymphocyte enriched cultures to produce 
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significantly larger titers of BVDV than did nonstimulated cultures. In 
contrast, immune leukocyte and lymphocyte enriched cultures produced 
lower titers of BVDV when stimulated with PHA than the nonstimulated cul-
tures. This may be explained by the ability of BVDV to inhibit PHA in-
duced ·nNA synthesis (Muscoplat et al. 1973a). This inhibition of mito-
genic stimulation by PHA in vi-tro has also been reported in naturally in-
fected lymphocytes obtained from a calf chronically infected with a non-
cytopathic isolate (Johnson and Muscoplat 1973). 
Calves infected with BVDV experience a generalized reduction in the 
cellular immune response. Experimentally infected calves experience an 
increased incidence of bacteremia, coinciding with PHA suppression of 
lymphocytes and leukopenia. This reduction in blood clearance efficiency 
has been attributed to BVDV induced impairment of macrophage and poly-
morphonuclear leukocyte (PMN) activities (Reggiardo and Kaeberle 1981). 
Reduction in phagocytic efficiency of macrophages may be related to the 
ability of macrophages to support BVDV replication (Truitt and 
Shechmeister 1973). Inhibition of the myeloperoxidase, hydrogen perox-
ide, halide system of PMN is evident by their reduced iodination ability 
as a result of BVDV infection (Roth et al. 1981). 
Antibody response is also affected by BVDV infection. Studies con-
ducted utilizing in vivo infected B lymphocytes and in vitro infected 
splenocytes have shown BVDV to suppress the release of cytoplasmic immu-
noglobulin. This suppression appears to be the result of failure in BVDV 
infected B lymphocytes to differentiate into mature plasma cells 
(Muscoplat et al. 1973b, Atluru et al. 1979) . 
• 
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Bovine viral diarrhea - fetal infection 
Another aspect of BVD occurs when pregnant heifers and cows are in-
fected with BVDV. Like other infections, clinical signs in the dams 
often are unnoticed except for an increase in reproductive failures. 
Reproductive failures are manifested as abortions, stillbirths, and the 
birth of calves with congenital defects. Pregnancy outcome is dependent 
on gestational age at which fetal infection occurs. 
The fourth month of gestation appears to be the point at which fetal 
susceptibility to BVDV decreases (Casaro et al. 1971). Infections occur-
ring prior to 100 days of gestation usually result in fetal death. The 
pregnancy may end in abortion, stillbirth or expulsion of a mummified 
fetus (Kahrs et al. 1970b, Casaro et al. 1971, Kendrick 1971, Scott et 
al. 1972). Lesions which have been reported in these fetuses include: 
alopecia due to follicular hypoplasia and cystic dilation of the adnexal 
glands, mild anasarcous, mandibular brachygnathism, cataracts, petechiae 
on conjunctiva, general nonsuppurative inflammatory changes, and necrosis 
with or without inflammation in skin, lung, and brain (Casaro et al. 197~ 
Kendrick 1971, Scott et al. 1972). 
If infection occurs between 100 and 180 days of gestation, these 
fetuses may survive to birth, but are born with a large number of con-
genital defects. Most notable is cerebellar hypoplasia. Clinically, 
these animals may be unable to stand at birth, have an abnormal stance, 
ataxia, dysmetria, and/or tremors (Wilson et al. 1983). Along with cere-
bellar hypoplasia, other central nervous system defects can be seen, in-
cluding microencephaly, internal hydrocephalus, cerebellar dysgenesis, 
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spinal cord hypoplasia and spinal dysmyelination, microglial myelin de-
ficiency, and hypomyelination of the optic nerve. Other lesions seen 
were cortical hypoplasia of thymus, vascular endothelial hyperplasia, 
perivascular mononuclear cuffing, complete loss of spermatogenic epi-
thelium, eye and optic nerve lesions resulting in blindness, and intra-
uterine growth retardation (Kahrs et al. 1970c, Scott et al. 1972, Brown 
et al. 1974, Brown et al. 1975, Done et al. 1980, Binkhorst et al. 1983, 
Duffell et al. 1984). 
When fetal infection takes place in the last trimester, viral spe-
cific antibodies are produced by the fetus. Immunologic competence is 
reached by the bovine fetus between 100 and 200 days of gestation (Braun 
et al. 1973). This immunologic response, as observed in the fetus, fol-
lows the expected pattern with the first immunoglobulin seen as IgM, fol-
lowed by IgG1 and IgG2 . Immunoglobulin M has been seen in fetuses at 95 
days of gestation, but specific viral neutralization activity was not de-
tected until 200 days of gestation (Braun et al. 1973, Brown et al. 
1974). This response enables the fetus to recover in utero from BVDV 
infection with no apparent adverse effects and to possess, at birth, a 
life long immunity. 
Another facet of fetal° BVDV infection is seen in the "weak calf syn-
drome". These calves appear normal at birth, but within hours of birth 
develop diarrhea of varying severity. Death may result from severe de-
hydration within 18 to 96 hours or chronic diarrhea may persist for 
several weeks. Clinical signs associated with this syndrome are repro-
ducible by infecting calves within the time period of 25 days prenatally 
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to 3 days postnatally. Severity of clinical signs is dependent on the 
timing of infection; if infected prenatally, the diarrhea is less severe 
than if the calf was infected at birth or within 3 days postnatally 
(Lambert et al. 1974). The severity of this infection could be directly 
related to the immunosuppression resulting from BVDV infection and the 
stress associated with birth (Roth and Kaeberle 1983). 
Persistent infection 
A fifth outcome of an in utero infection has recently been recog-
nized in a small proportion of the cattle population. This infection 
results in apparently healthy, persistently infected adult cattle (Coria 
and McClurkin 1978). Persistently infected cattle may appear to be fully 
recovered from neurological disorders present at birth or to be clini-
cally normal (Straver et al. 1983, Mcclurkin et al. 1984). Preliminary 
surveillance indicates the incidence of persistently infected cattle may 
occur in nearly 2% of the cattle population within the United States 
(Bolin et al. 1985b). 
Mcclurkin et al. (1984) succeeded in experimentally producing per-
sistently infected calves by infecting the fetus prior to day 123 of 
gestation with several isolates of BVDV. In these experiments, only the 
noncytopathogenic isolates could establish persistence; the cytopatho-
genic isolate, NADL, could not establish persistence. Not all of the ex-
perimentally infected fetuses resulted in persistently infected calves. 
As expected, stillbirths, abortions, and weak calves also occurred since 
the time interval for production of all four events coincide (Mcclurkin 
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et al. 1984). It is generally believed that ·the majority of the persis-
tently infected calves found in the field are the offspring of persis-
tently infected cows or first calf heifers undergoing a BVDV infection 
during the first trimester (Straver et al. 1983, McClurkin et al. 1984). 
Persistently infected cattle lack the clinical signs which indicate 
the continued presence of virus. Similarly, the gross lesions associated 
with viral infections are not seen at necropsy of persistently infected 
animals. It is only upon microscopic examination that lesions indicating 
the presence of a glomerulonephritis and encephalitis can be seen. In 
spite of the wide distribution of viral antigens in the spleen, lymph 
nodes, epithelial cells of the small intestine and seminiferous tubules, 
and vascular endothelium of the lung, liver, adrenal gland, heart, and 
aorta; lesions are not observed (Cutlip et al. 1980). 
The immunological status of persistently infected cattle has not 
fully been evaluated. Limited studies have shown levels of serum pro-
teins to be lower than average, but immunoglobulins were within the nor-
mal range of healthy cattle (Coria and Mcclurkin 1978, Coria et al. 
1983a). Persistently infected cattle are immunocompetent to antigens 
other than BVDV. A persistently infected bull responded with production 
of antibodies to a chlamydial infection; but when given a triple dose of 
BVDV vaccine, it failed to produce a significant anti-BVDV titer (Coria 
and Mcclurkin 1978). This immunologic tolerance of BVDV seen in per-
sistently infected cattle may not be absolute. The glomerulonephritis 
present in these cattle appears to be very similar to that found in 
murine lymphocytic choriomeningitis. If this similarity is confirmed, 
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then the glomerulonephritis seen in cattle persistently infected with 
BVDV would be due to deposition of immune complexes on basement membranes 
of the glomeruli (Cutlip et al. 1980). 
Mucosal disease 
Clinical signs seen in young cattle with mucosal disease (MD) are 
fever, anorexia, suspension of rumination, depression, nasal discharge 
which is at first watery but becomes more viscid as the clinical signs 
advance. Often a sero-mucoid exudate is seen hanging from the nares and 
muzzle. Erosions and ulcers develop on the muzzle, nares, within the 
mucosa of the oral cavity, including the tongue and gingivae, pharynx, 
esophagus, and intestinal tract. Severity of these lesions often advance 
to such a degree that the mucosal surface is almost entirely absent from 
the affected tissues. As the lesions advance, profuse and violent diar-
rhea occurs first as watery feces, and later becoming more scanty, con-
sisting largely of blood and mucus. In terminal stages, the calf experi-
ences violent tenesmus (Childs 1946, Ramsey and Chivers 1953, Ramsey 
1956, Pritchard 1963, Peter et al. 1967). 
Cattle afflicted with MD possess similar immunologic capabilities as 
normal, healthy age-mates, except the ability to respond immunologically 
to BVDV. The incidence and levels of neutralizing antibodies to other 
common bovine viruses and the ability to respond immunologically to fer-
ritin are similar in both healthy and fatally affected cattle. This 
corresponds with the relatively normal levels of immunoglobulins found 
in the MD affected cattle. These animals have normal levels of lgG, lgM, 
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and IgA; however, when the IgG classes are determined individually, lgG2 
is considerably lower than that found in healthy age-mates (Steck et al. 
1980). These cattle may be able to respond to superinfection by a cyto-
pathic BVDV with the production of neutralizing antibodies, but only if 
the superinfecting isolate is antigenically distinct from the noncyto-
pathic isolate producing the viremia and only after a considerable length 
of time (Peter et al. 1967, Steck et al. 1980, Bolin et al. 198Sa, Bolin 
et al. 1985c). 
Lymphocytes of cattle fatally affected with MD have a reduced abil-
ity to respond to PHA and concanavalin A (Con A) (Steck et al. 1980). 
This aspect of the cellular immune response of cattle affected with MD 
is similar to that of BVD affected cattle (Johnson and Muscoplat 1973); 
however, MD differs from BVD in the occurrence of leukopenia. In MD, 
leukopenia occurs prior to the appearance of marked clinical signs and is 
followed by leukocytosis (Bolin et al. 1985a); while leukopenia occurs 
between the two febrile responses in BVD (Pritchard 1963). 
Cattle succumbing to MD had remained BVDV seronegative in spite of 
originating from a BVDV seropositive herd (Thomson and Savan 1963, 
Malmquist 1968, Kahrs et al. 1970a, Liess et al. 1974, Steck et al. 1980, 
Brownlie et al. 1984, Roeder and Drew 1984, Bolin et al. 1985c). Since 
cytopathic BVDV was routinely isolated from these outbreaks of MD 
(Underdahl et al. 1957, Gillespie et al. 1961, Thomson and Savan 1963, 
Kahrs et al. 1970a); the possibility of noncytopathic BVDV infection 
playing a role in MD was not readily recognized until persistent BVDV in-
fections of seronegative cattle had been established (Coria and Mcclurkin 
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1978). This involvement has been further confirmed by McClurkin et al. 
(1985) with the isolation of both cytopathic and noncytopathic BVDV from 
16 of 17 spleens obtained from cattle diagnosed as having MD. Many of 
the field cases of MD result from vaccinating apparently healthy persis-
tently infected cattle (Peter et al. 1967, McKercher et al. 1968, 
Mcclurkin et al. 1985). Clinical signs of MD have now been experimen-
tally reproduced, which are identical to the clinical signs seen in the 
field, by superinfecting persistently infected calves with cytopathic 
BVDV (Brownlie et al. 1984, Bolin et al. 1985c). 
Characteristics of Bovine Viral Diarrhea Virus 
Serological and cultural characteristics 
The fact that a noncytopathic and a cytopathic isolate of BVDV are 
required for the manifestation of MD indicates that distinct differences 
may exist between the isolates of BVDV. During the last several decades, 
various isolates have been compared and significant differences between 
them have not been demonstrated (Gillespie et al. 1961, Fernelius et al. 
1971, Horzinek 1981). Limited in vivo studies concerning the pneumo-
pathogenicity of BVDV in susceptible calves have indicated that the cyto-
pathic isolates may result in the expression of more severe clinical 
signs than those of the noncytopathic isolates (Potgieter et al. 1985). 
The most pronounced difference between the various isolates is the 
degree to which a particular isolate is cytopathic in cultured bovine 
cells. The first isolates identified as BVDV were noncytopathic. In 
1960, Gillespie et al. (1960) reported the isolation of a cytopathic 
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agent, Oregon C24V (C24V), from a calf with clinical signs very similar 
to those associated with noncytopathic BVDV. Soon after this report, 
other cytopathic isolates were obtained, including ClK, C56K, and NADL 
(Gillespie et al. 1960, Gutekunst and Malmquist 1963). 
Another difference associated with the cytopathogenicity of the 
isolates is the viral multiplication rate. In vitro growth rate of the 
cytopathic isolates is much higher than that of the noncytopathic iso-
lates. Since viral replication of the noncytopathic isolates does not 
destroy the cell, a longer period of time exists in which virus can be 
released. This fact results in total virus yields per cell for both the 
cytopathic and noncytopathic BVDV to be comparable (Mahnel and von Moreau 
1984). However, the cytopathic and noncytopathic isolates respond dif-
ferently when actinomycin D is included in the cell culture medium. The 
replication rate for cytopathic isolates appears to be reduced by 30% to 
100%, contrasted by that of the noncytopathic isolates which is increased 
20% to 100% (Nuttall 1980). 
Oregon C24V and NADL isolates each produce a cytopathic effect (CPE) 
which is distinct. The CPE produced by C24V is characterized by the for-
mation of vacuoles of various sizes, the nuclei are pyknotic and often 
eccentric, with a few cells rounding-up and detaching from the growth 
surface. The prominent feature of the CPE produced by NADL is the pyk-
notic nuclei prior to rounding-up and detachment of the cell from the 
growth surface. The NADL isolate does not produce the vacuolation which 
is so evident in C24V (Fernelius and Ritchie 1966). Fernelius et al. 
(1971) proposed a classification system for BVDV based on the CPE pro-
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duced. The 3 categories, or biotypes, proposed in this system are char-
acterized by the CPE produced by NADL and C24V and the absence of CPE. 
Slight antigenic differences have been observed between the various 
isolates. These differences can be demonstrated by immunofluorescence 
and viral neutralization. Fernelius (1964) reported that noncytopathic 
isolates fluoresced with the greatest intensity when the conjugate used 
was prepared with antiserum produced against a noncytopathic isolate. 
However, the cytopathic isolates fluoresced to equal intensity with 
either conjugated antiserum, anti-NADL (cytopathic) or anti-CG1220 (non-
cytopathic). 
A greater variation is seen in the abilities of the various isolates 
to be neutralized by heterologous antiserum. Gillespie et al. (1961) 
compared the ability of a single anti-BVDV antiserum to neutralize six 
isolates from various sources. All of the isolates were neutralized by 
the antiserum but the neutralization indexes varied from 102 ' 5 to 105 ·0 
TCID50 . Fernelius et al. (1971) pursued this difference in degree of 
viral neutralization and proposed 3 BVDV serotypes, C24V, NADL, and non-
cytopathic. Fernelius et al. (1971) compared these serotypes in viral 
neutralization tests, and found each serotype to be neutralized to a 
greater degree with its homologous antiserum than with heterologous anti-
sera. In immunization experiments, this group also found that when an 
immunized animal was given a hyperimmunizing dose of a heterologous sero-
type, antibodies specific for the heterologous serotype were not formed. 
However, the immunized animal was protected from challenge with the 
heterologous serotype illustrating that though various BVD isolates may 
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differ serologically, they are still immunologically very similar 
(Castrucci et al. 1975). 
Fernelius et al. (1969a, 1969b) were successful in changing the bio-
types of C24V and NADL by serial passages in the PK-15 cell line, embry-
onic bovine kidney cell line (EBK) and rabbits. The altered biotypes re-
sulted in PK-15 cell passaged C24V producing NADL type CPE; PK-15 and EBK 
passaged C24V resembling noncytopathic BVDV in culture, and rabbit pas-
saged NADL producing C24V type CPE. With the change in biotype, the 
serological specificity changed to that of the new biotype. Thus, PK-15 
passage C24V had the highest neutralization titers with anti-NADL, PK-15 
and EBK passaged C24V with anti-CG1220, and rabbit passaged NADL with 
anti-C24V. This group speculated that the characteristics of CPE are 
genetically linked to the serological specificity (Fernelius et al. 1971). 
Coria et al. (1984) have reported the failure of BVDV to be neutral-
ized by antiserum to heterologous soluble antigen (sAg). The antiserum 
used was produced against sAg protein isolated by high performance gel 
permeation chromatography. Coria and coworkers demonstrated that this 
antiserum, produced against specific proteins of the NY-1 sAg, would neu-
tralize the NY-1 isolate, but not the Singer or NADL isolates. Similarly, 
the antiserum produced against proteins of the Singer sAg would neutral-
ize both Singer and NADL, but not the Ny-1 isolate. This fact seems to 
indicate the differences lie not with the whole virion, but rather with 
the sAg which is produced by the infected cell. 
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Replication 
The method of replication which characterizes members of the Toga-
viridae family is illustrated by the 8emliki Forest and 8indbis viruses, 
members of the Alphavirus genus. The polyadenylated 428 genome of these 
viruses is replicated in two segments on membrane bound cytoplasmic poly-
ribosomes. After uncoating within the infected host cell, one large 
polypeptide is translated. This polypeptide represents the first 1/3 
of the 5' terminus of the genome. From this polypeptide, 4 nonstruc-
tural proteins are cleaved, two of these compose the RNA polymerase which 
transcribes the viral +RNA to the -RNA template. From the -RNA template, 
two <·RNA groups are transcribed: a full length RNA to serve as mRNA, 
template for -RNA and RNA for encapsulation; and a 268 length which 
represents the other 1/3 of the genome. This 268 length contains the 
code for the 4 structural proteins cleaved from the 130 kilodalton (kd) 
precursor (Joklik 1980, Joklik et al. 1984). 
Replication of BVDV differs from that of the segmented genome of the 
alphaviruses. Bovine viral diarrhea virus appears to replicate similar 
to Uganda 8 and West Nile viruses, members of the Flavivirus genus of 
the Togaviridae family. Extracted RNA from these viruses does not bind 
to oligodeoxythymidylate cellulose indicating its lack of a polyadenylated 
tail and resulting independence of membrane-associated replication. A 
single large polypeptide precursor has not been detected, suggesting that 
the genome of these three viruses serves directly as mRNA for the viral-
coded proteins. Direct coding in the viral RNA for the structural pro-
teins implies the existence of multiple functional initiation sites on 
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the viral RNA (Porterfield et al. 1978, Purchio et al. 1983, Purchio 
et al. 1984a, Joklik et al. 1984). 
In vitro translation of the BVDV genome in message-dependent reticu-
locyte lysates resulted in the synthesis of a broad spectrum of BVDV spe-
cific proteins. Only when polysome-associated RNA was isolated from in-
fected cells and added to the reticulocyte lysate, did the two resulting 
proteins comigrate in sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) with the previously identified viral 115 kd and 80 kd 
proteins (Purchio et al. 1984b). This suggests that factors are present 
on the polysome-associated RNA which allow for the appropriate termina-
tion of the synthesized polypeptides. 
Assembly of the BVD virion and maturation occurs in cellular vesi-
cles (Ohmann and Bloch 1982, Mahnel 1984). During viral replication, 
smooth bi- and multilayered membrane fragments are formed. The viral 
specific proteins, produced either free in the cellular cytoplasm or in 
association with the membraneous structures, accumulate in a fibrillar 
material. As the membrane fragments interact to form vesicles, the 
fibrillar material and viral proteins are internalized. Bovine viral 
diarrhea virus has not been observed budding through the cytoplasmic mem-
branes (Ohmann and Bloch 1982, Mahnel 1984) which is in contrast to the 
morphogenesis of other togaviruses, including hog cholera virus (Scherrer 
et al. 1970). Mature BVD virions appear to be released from viable cells 
by exocytosis as would be the case with noncytopathic BVDV, and by dis-
integration of the vesicle after cell death as with cytopathic BVDV. 
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Structural characteristics 
Bovine viral diarrhea virus is a member of the genus Pestivirus of 
the family Togaviridae. Other viruses belonging to this group of non-
arthropod-borne togaviruses include hog cholera virus, border disease of 
sheep, equine arteritis virus, lactic dehydrogenase virus of mice and 
simian haemorrhagic fever virus (Horzinek 1981). Of the viruses listed 
above, BVDV, hog cholera, and border disease are known to be related, at 
least on a serological basis (Darbyshire 1962, Osburn et al. 1973, Plant 
et al. 1973, Horzinek 1981). 
The diameter of the pleomorphic BVD virion has been reported to be 
between 40 and 60 nanometers (nm) (Horzinek 1981). A recent report (Chu 
and Zee 1984) indicated the viral particle to be much larger, measuring 
120 (+/-30) nm in diameter. Surrounding the nucleocapsid was a 5 to 7 nm 
thick membrane-like envelope with distinct knob-like projections, 4 to 5 
nm in diameter. Chu and Zee did find particles in their preparations 
which matched the 40 to 60 nm particles reported earlier. These parti-
cles found in the noninfective fractions did form aggregates with BVDV-
specific antiserum, indicating their relatedness to the BVD virion. The 
authors speculated that these particles may possibly be the viral cores 
or fragments of disintegrating virions. 
Bovine viral diarrhea virion has been determined to contain RNA by 
its ability to replicate in the presence of 5-iododeoxyuridine. Upon 
extraction, the RNA was infectious, resistant to DNase, but sensitive to 
RNase (Diderholm and Dinter 1966). Initial characterization indicated 
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the BVD viral genome consisted of 3 single-stranded segments. The larg-
est segment having a sedimentation coefficient of 38S with a correspond-
ing molecular weight of 3.22 x 106 daltons (d). The two smaller segments 
observed had sedimentation coefficients of 31S (2.19 x 106 d) and 24S 
(1.22 x 106 d) (Pritchett et al. 1975). The significance of the various 
segments of RNA isolated from BVDV was not determined by these authors; 
however, they did propose several explanations which included the exis-
tence of a polyploid genome, random degradation of the genome, and a seg-
mented genome. Others have shown the BVD genome to be a single segment 
(Felmingham and Brown 1977, Purchio et al. 1983). Felmingham and Brown 
(1977) were successful in isolating two forms of viral RNA, a single-
stranded form and a double-stranded replicative form as determined by in-
creased resistance of the double-stranded form to hydrolysis by RNase. 
The most recent study of Purchio et al. (1983) found the BVD virion to be 
composed of a single 33S length of RNA with a molecular weight of 2.9 x 
106 d, representing 8.2 kilobases (kb). 
Identification of the structural proteins has not been fully deter-
mined. Frost and Liess (1973) did initial studies which identified 3 
proteins within the virion; however, determination of the molecular 
weights was not included in this report. Pritchett and Zee (1975) re-
ported the occurrence of 5 polypeptides within the BVD virion. These 
identified polypeptides were reported to have molecular weights of 93-
110 kd, 70 kd, 50-59 kd, 39 kd, and 27 kd. Other reports on the numbers 
of polypeptides composing the BVD virion and their estimated molecular 
weights include: Felmingham and Brown (1977) observing polypeptides of 
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144 kd, 117 kd, and 100 kd; Matthaeus (1979), 57 kd, 44 kd, and 34 kd; 
and Coria et al. (1983b) 75 kd, 66 kd, 54 kd, and 26 kd. 
Akkina (1982) and Purchio et al. (1984a) reported the presence of 
5 polypeptides in dissociated BVDV. The reported molecular weights of 
these 5 polypeptides are 115 kd, 80 kd, 54 kd (55 kd, Purchio et al.), 
45 kd, and 35 kd (38 kd, Purchio et al.). Akkina (1982) had also in-
cluded a noncytopathic isolate of BVDV in his study. The noncytopathic 
isolate studied possessed the 115 kd polypeptide, but not the 80 kd. 
Akkina speculated that noncytopathic isolates were unable to further 
process the 115 kd polypeptide into the 80 kd polypeptide. Recently, 
Purchio et al. (1984a) demonstrated a structural similarity between the 
115 kd and the 80 kd polypeptide, but a precursor-product relationship 
was not shown. 
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MATERIALS AND METHODS 
Virus 
Six isolates of BVDV are included in this study; three cytopathic, 
NADL,.Singer, and TGAC; and three noncytopathic, 7443, NY-1, and Tifton. 
Bovine viral diarrhea isolate 7443, was isolated from a persistently in-
fected bull (Coria and McClurkin 1978), and TGAC and Tifton were isolated 
from a clinical case of MD (Bolin et al. 1985a). The isolates were propa-
gated on monolayers of bovine turbinate cells (BT). The culturing fluid 
consisted of Eagles minimum essential media with Earles salts (EMEM) 
supplemented with 0.25% lactalbumin hydrolysate and 15% adult ovine serum 
known to be free of BVD, border disease, parainfluenza type 3 (PI-3), and 
infectious bovine rhinotracheitis (IBR) viruses and antibodies. Four-
day-old cultures were inoculated with virus at high multiplicity of in-
fection. The virus was allowed to adsorb for 1 hour at 37° C. Culturing 
fluid was replaced with EMEM without serum supplement. Cytopathic iso-
lates were harvested when cytopathic effect had involved 80 to 90% of 
the cell sheet. Noncytopathic isolates were harvested after 7 days. 
Reagents 
Anti-BVDV antiserum was prepared in a calf known to be free of BVD, 
IBR, Pl-3, and bovine parvovirus and also free of antibodies to these 
viruses. The calf was given an initial inoculation of 10 ml of BVDV-NADL 
intravenously. One year later, a second intravenous inoculation of 50 ml 
of BVDV-NADL was administered. The antiserum obtained 3 weeks post-
infection had a serum neutralization titer to BVDV of 1:8192. 
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Bovine anti-BT antiserum was prepared against BT cultures maintained 
in EMEM with 10% bovine serum in a known BVD virus and antibody free calf. 
Three 20 ml intravenous injections were given at intervals of 9 and 11 
days. The antiserum obtained 10 days post-inoculation had remained free 
of BVDV serum neutralization antibodies. 
Normal bovine serum was obtained from calves housed in isolation and 
known to be free of BVD virus and antibody. 
Immunoglobulins were precipitated with ammonium sulfate from the 
various bovine sera as described by Garvey et al. (1977). 
Goat anti-bovine immunoglobulin was purchased from Nordic Immuno-
logical Laboratories (Tilburg, Netherlands). 
Rabbit anti-bovine immunoglobulin antiserum was purchased from 
Cooper Biomedical (Malvern, PA). 
Biotinylated Protein A (BPA) and horseradish peroxidase conjugated 
streptavidin (SA-HRP) were purchased from Zymed Laboratories, Inc. (So. 
San Francisco, CA). 
Iodine [125] labeled Protein A <125IPA) with a specific activity of 
greater than 30 mCi/mg was purchased from Amersham (Arlington Heights, 
IL). 
Purification of Virus 
The infected cultures for each isolate were harvested and pooled. 
An equal volume of uninfected cells and culture medium was also subjected 
to the viral purification procedures to serve as a BT cell control. 
The pooled culture fluids were subjected to two cycles of freezing 
and thawing and clarified by centrifugation at 10,000 x g for 1 hour at 
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4° c. Each pool was made 10 mM with respect to ethylenediaminetetraacetic 
acid (EDTA). The volume of each pool was reduced to approximately l/15th 
of the original volume by hydroextraction with polyethylene glycol (PEG) 
20,000 through 10,000 MW exclusion dialyzing tubing at 4° C (Coria et al. 
1983b) or by ultrafiltration (Pellicon Cassette System, Millipore, 
Bedford, MA) over a membrane with an exclusion limit of 1 x 106 daltons. 
The virus and BT cell control concentrates were further purified by 
affinity chromatography using the lectin Ricinus communis agglutinin 
(RCA) coupled to CH Sepharose 4B (US Biochemical, Inc., Cleveland, OH). 
The coupled sepharose was packed in a 1.6 x 30 cm chromatography column 
and kept at 4° C. The concentrates were placed on the RCA lectin column 
and allowed to adsorb for 18 hours. Following extensive washing of the 
column with O.lM phosphate buffer saline pH 7.1 (PBS), the bound material 
(eluate) was eluted with 0.2M lactose in PBS. The eluates were then col-
lected and concentrated by hydroextraction as previously described or by 
ultrafiltration with Immersible CX-30 Filters (Millipore, Bedford, MA). 
Portions of the eluates were lyophilized in 100 µl aliquots. 
Protein content of the cell culture stock, cell culture concentrate, 
and eluate, were determined by the BioRad Protein Assay (BioRad, Richmond, 
CA) (Table 1). 
Virus titers were determined for each fraction by inoculating consec-
utive 10-fold dilutions onto BT cells (Table 1). The BT cells were either 
grown in microtiter plates for the detection of cytopathic effect or on 
coverslips and subsequently examined for BVDV specific immunofluorescence. 
31 
High Performance Gel Permeation Chromatography 
Lyophilized RCA lectin eluates were subjected to high performance 
gel permeation chromatography (HPgPC) (Millipore, Bedford, MA) in both 
native and denatured states (Montelaro et al. 1981). For determination 
of native polypeptides, the eluates were reconstituted in 100 µl in lOmM 
sodium phosphate, 50•11'1 sodium chloride buffer pH 7. Denaturing condi-
tions wern achieved by including 1.0% sodium dodecyl sulfate (SDS) in 
the reconstituting buffer and subsequent heating to 100° C for 3 minutes. 
The mobile phase for the nondenaturing system was lOmM sodium phosphate, 
50~1 sodium chloride pH 7; for the denaturing system, 0.1% SDS was in-
cluded in the mobile phase. Both systems were run isocratically at 0.7 
ml/min. on tandem 7.5 x 300 mm TSK 3000 SW columns (Beckman Instruments, 
Inc., Berkeley, CA). This column has a separation range of 30 kilodal-
tons (kd) to 500 kd under nondenaturing conditions and 10 kd to 100 kd 
under denaturing conditions. Chromatographs were determined by ultra-
violet absorbance at 280nm. 
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Horizontal sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) (LKB-Produkter AB, Bromma, Sweden) was performed in 7.5% 
acrylamide gels (Fehrnstrom and Moberg 1977). Prior to being placed on 
the slab gels, lyophilized eluates were reconstituted to 100 µl in 0.1% 
SDS, 1.0% 2-mercaptoethanol, O.lM phosphate buffer pH 7.1 and solubilized 
by heating to 100° C for 3 minutes. Ten microliters of each eluate and 
commercial standards (BioRad, Richmond, CA) having a range of 14.4 kd 
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to 92.5 kd were placed on the gel and electrophoresed at 5 v/cm for 5 
hours. The resulting protein bands were stained with Coomassie-blue 
R-250. 
Discontinuous SDS-PAGE was performed as described by Laemmli (1970) 
with the following modifications: eluates were diluted 1:2 in sample 
buffer which did not contain 2-mercaptoethanol and the resolving gel was 
cor.1posed of 7 .5% acrylamide. After solubilizing by heating at 100° C for 
3 minutes, 100 µl of each eluate and 50 µl of both high (40 kd to 250 kd) 
and low (14.4 kd to 92.5 kd) molecular weight commercial standards (Bio-
Rad, Richmond, CA) were placed on the gel and electrophoresed at 30 mAmp 
per gel for 2.5 hours or until the bromphenol blue tracking dye had mi-
grated off the end of the gel. 
Western Blotting 
Gels used for Western blotting were run in a vertical slab gel appa-
ratus (LKB Produkter AB, Bromma, Sweden) and soaked in a renaturing buf-
fer composed of 50mM sodium chloride, lOmM Tris, 2mM EDTA, and 4M urea 
pH 7.0 for 30 min. at room temperature (V. Moennig, Department of Veter-
inary Microbiology, College of Veterinary Medicine, Iowa State University, 
Ames, Iowa, Personal Communication). Nitrocellulose replicas of the gels 
were made by electrophoretic transfer in a Trans-blot Cell (BioRad, 
Richmond, CA). Electrophoretic transfer was conducted under cooling con-
ditions at 85V for 2 hours in 20% methanol, 25mM Tris base, 192mM gly-
cine, pH 8.3 buffer (Towbin et al. 1979). 
Nitrocellulose replicas were blocked in 5% fraction V bovine serum 
albumin (BSA), 20mM Tris buffered saline pH 7.5 for 1 hour on a rocking 
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platform. Prior to blocking, the nitrocellulose replicas of the molecu-
lar weight standards were stained with India ink as described by Hancock 
and Tsang (1983). 
Detection of Proteins on Nitrocellulose Replicas 
For the BPA/SA-HRP system, the nitrocellulose replicas were treated 
consecutively with each of the following reagents for 2 hours at room 
temperature on a rocking platform: a 1:5 dilution of the primary anti-
serum or 1:10 dilution of primary immunoglobulin, a 1:1000 dilution of 
the rabbit anti-bovine antiserum, a 1:1000 dilution of BPA, and 1:1000 
dilution of SA-HRP. The diluent was 20mM Tris buffered saline pH 7.5 
(TBS) with 1.0% BSA (TBS-BSA). Three 10 min. washes with 0.05% Tween-
20 TBS (TTBS) on a rocking platform followed each incubation period. 
The horseradish peroxidase was developed with BioRad HRP color develop-
ment reagent (BioRad, Richmond, CA). 
When IPA was used, the nitrocellulose replicas were reacted with a 
1:200 dilution of goat antibovine immunoglobulin following the primary 
immunoglobulin. After three 10 minute TTBS washes, 1 µCi of 1251PA in 
TBS-BSA was placed on each nitrocellulose replica and incubated for 1 
hour at room temperature on a rocking platform. Following three 10 
minute washes with TTBS, the replicas were exposed to Kodak XAR-5 at 
-70° C for 4 to 48 hours (Lum and Reed 1983). 
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RESULTS 
Purification of BVDV with Ricinus communis Agglutinin Lectin 
Purification parameters obtained with the RCA lectin method using 
6 isolates of BVDV were inconsistent (Table 1). Low percentages of in-
fectivity were recovered for 3 isolates, 8% for TGAC, and 1% for NADL 
and NY-1. For the remaining isolates, the percentage of recovered in-
fectivity was higher, 80% for Singer, 160% for Tifton, and 200% for 
7443. With the latter virus preparations, some concentration was 
achieved. In the best case (isolate 7443), 80-fold (1.9 log10) purifi-
cation was recorded. 
High Performance Gel Permeation Chromatography 
The isolates examined by HPgPC were NADL, NY-1, Singer, and 7443, 
along with the BT cell control. In the nondenaturing system, the major 
portion of the viral and BT cellular proteins came off the column in the 
void volume having a molecular weight of greater than 440 kd. A second-
ary peak in the molecular weight range of 66 kd to 96 kd was seen for 
NADL, NY-1, and 7443 (Figure 1). 
In the denaturing system, an increase in numbers and a decrease in 
molecular weight of the polypeptides were seen for the four virus prepa-
rations and the BT cell control (Figure 2). The major peak occurred in 
the molecular weight range of 45 kd to 66 kd, with a secondary peak 
smaller than the 12.5 kd marker. Several small peaks were observed 
within the primary peak, but distinct differences could not be seen be-' 
tween the individual virus isolates and/or the BT cell control. 
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Table 1: Infectivity of BVDV during concentration and purification by 
hydroextraction and affinity chromatography 
Preparative Total Recovery Total Infectivity 
Steps Infectivity (%) Protein (ID50/mg 
(ID50 ) 
(mg) protein) 
Singer 
109.2 107.3 Stock 100 75 
Concentrate 109. 5 200 115 107.4 
Eluate 109.1 80 5 107 .3 
NADL 
109.3 107 .4 Stock 100 80 
Concentrate 108.0 5 107 106.0 
Eluate 107.1 1 19 105.8 
TGAC 
108.0 106.3 Stock 100 47 
Concentrate 107.3 20 65 105. 5 
Eluate 106.9 8 7 106.l 
7443 
109.0 106.9 Stock 100 44 
Concentrate 109.2 160 88 107 .3 
Eluate 109.3 200 3 108.8 
NY-1 
107.0 104.8 Stock 100 56 
Concentrate 106.2 16 88 104.3 
Eluate 105.l 1 8 104.2 
Tifton 
107 .6 105 .9 Stock 100 50 
Concentrate 107. 7 126 115 105. 6 
Eluate 107.8 160 18 106. 6 
BT Cell 
Control 
Stock 50 
Concentrate 98 
Eluate 17 
Figure 1 HPgPC tracings of the native polypeptides obtained from 
nondenatured BVD virus preparations. Arbitrary values 
have been assigned to the ordinate scale 
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Figure 2 HPgPC tracings of the polypeptides obtained from denatured 
BVD virus preparations. Arbitrary values have been assigned 
to the ordinate scale 
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Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
Continuous SDS-PAGE of NADL, NY-1, Singer, 7443, and BT cell control 
resulted in the separation of several polypeptides (Figure 3). The esti-
mated molecular weights of the separated polypeptides of the four isolates 
were similar to those.previously reported by Pritchett and Zee (1975), 
Felmingham and Brown (1977), Matthaeus (1979), Akkina (1982), Coria et al. 
(1983b), and Purchio et al. (1984a). The virus preparations and the BT 
cell control each had 5 polypeptides which migrated to similar distances 
from the origin and ranged in molecular weights from 24 kd to >92.5 kd. 
Variations between the virus isolates and BT cell control could be noted. 
The variations were contained within 4 molecular weight ranges. Isolates 
NADL, 7443, and NY-1 had additional bands above the 92.5 kd marker, while 
NADL and Singer had several bands in the molecular weight ranges of 30 kd 
to 50 kd and <20 kd. The fourth area of variation is in the molecular 
weight range of 80 kd to 90 kd, with NADL having the only band. 
Isolates Singer, NADL, TGAC, 7443, NY-1, and Tifton, along with the 
BT cell control were also examined with discontinuous SDS-PAGE (Figure 
4). Banding patterns for all of the virus isolates and BT cell control 
were relatively similar·with variations occurring in 3 molecular weight 
areas. All of the virus preparations and the BT cell control had a band 
within the molecular weight range of 66 kd to 95 kd; however, individual 
locations varied. Isolates NADL, TGAC, Tifton and the BT cell control 
each had a band within molecular weight ranges of 45 kd to 50 kd and 35 
kd to 40 kd. Isolate 7443 also has a band within the molecular weight 
range of 35 kd to 40 kd. 
Figure 3 Continuous SDS-PAGE of BVD isolates 7443, NY-1, Singer, and 
NADL, and the BT cell control. Molecular weight standards 
are included 
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Figure 4 Discontinuous SDS-PAGE of BVD isolates Singer, NADL, TGAC, 
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Identification of Viral Specific Protein 
Antigenic reactivity could not be observed on the nitrocellulose 
replicas when the standard method, as described by Leammli (1970) was 
followed; or if this method was modified by the elimination of 2-
mercaptoethanol from the electrophoretic denaturing buffer. Only after 
soaking in the renaturing buffer prior to trans-blotting was antigenic 
reactivity restored. 
Reactions of specific antibody-antigen complexes on the renatured 
nitrocellulose replicas with BPA and SA-HRP were weak. In order to in-
. . . . b ' . 1 b l' d 125IPA d crease sensitivity, goat anti- ovine immunog o u in an were use • 
Two polypeptides in the virus preparations and one in the BT cell 
control were labeled on the nitrocellulose replicas by specific BVDV 
immunoglobulin. The larger molecular weight polypeptide was seen in 
both isolates and BT cell control while the smaller polypeptide was 
present only in the virus isolates. Molecular weights of these poly-
peptides exceeded 200 kd. 
Anti-BT immunoglobulin also labeled a polypeptide with a molecular 
weight of greater than 200 kd in the six isolates and the BT cell con-
trol. This polypeptide corresponds to the larger polypeptide labeled 
by specific BVDV immunoglobulin. 
Immunoglobulin obtained from a normal calf failed to label any 
polypeptides on the nitrocellulose replicas of the six virus prepara-
tions and the BT cell control. 
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DISCUSSION 
Purification methods which result in recovery of relatively high 
levels of infectivity for most viruses are not effective with BVDV. 
These physical methods are believed to disrupt the BVD viral envelope, 
reducing infectivity. In order to recover more infectivity by avoiding 
mechanical stress, Moreno-Lopez et al. (1981) proposed a gentler purifi-
cation method. This method involved the use of affinity chromatography 
with Crotalaria juncea (Cj) lectin which binds the viral particles via 
terminal galactosyl residues. Since the Cj lectin has a greater affin-
ity for galactose when a glucosyl residue is adjacent, the virus is 
easily desorbed from the lectin with lactose. Using this method, Moreno-
Lopez et al. (1981) were able to recover 653 of the BVD viral infectivit~ 
but could not demonstrate the presence of any intact viral envelopes in 
the purified preparations when these were examined by negative stain 
electron microscopy. Coria et al. (1983b) successfully showed in nega-
tive stain electron micrographs that the viral envelope is left intact 
during this purification method. 
Another lectin with the same affinity as the Cj lectin, Ricinus 
communis agglutinin (RCA), was used by Neukirch et al. (1981) to purify 
hog cholera virus. Using this lectin in affinity chromatography, 
Neukirch et al. recovered 403 to 603 of the hog cholera virus infectiv-
ity. 
Purification of BVDV with the RCA lectin was attempted, since hog 
cholera virus and BVDV belong to the same virus group. The inconsis-
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tency seen in the purification of six BVD isolates using this method 
does not fully support the reported effectiveness of viral purifica-
tion by affinity chromatography with RCA lectin. The difference in the 
rates of concentration and purification between the various isolates 
can not be easily explained (Table 1). Infectivities recovered as a 
result of RCA lectin affinity chromatography for 7443 and Tifton were 
2003 and 1603 respectively. This high yield of infectivity is in con-
trast to that seen for isolates NADL, TGAC, and NY-1, which had infec-
tivity reduced to less than 103. Eighty percent of the infectivity was 
recovered for Singer. This rate is in closer agreement with rates re-
ported earlier for affinity chromatography. 
The step which appears to be most critical in the purification pro-
cedure is concentration by hydroextraction. When total infectivity in 
the concentrate was reduced by> 0.7 log10 of virus, as for isolates 
NADL, TGAC, and NY-1, low levels of total infectivity were recovered 
from the RCA column (eluate). In contrast, when total infectivity was 
increased in the concentrate, as for Singer, 7443, and Tifton, higher 
levels of total infectivity were obtained in the eluate. 
Explanations for the increase in infectivity at this step are con-
jectural. The conc.entrates were derived from hydroextraction of the 
cell culture lysates (stocks) with PEG-20 at 4° C for up to 36 hours. 
During this time period, cellular hydrolases released as a result of 
freezing and thawing of the stocks had the opportunity to degrade mem-
brane-bound vesicles in which viral maturation occurred, liberating 
more viral particles (Ohmann and Bloch 1982, Mahnel 1984). In contrast, 
48 
aliquots of the stocks reserved for titration were held at -90° C, pre-
venting the degradation of the vesicles. Low molecular weight poly-
ethyleneglycol, which may have crossed the dialyzing membrane, could 
also be responsible for additional degradation of the infectious ves-
icles. This may be especially true for the noncytopathic isolates 
since their replication does not destroy the cell, and hydrolases are 
not present in significant amount in the cell culture supernatant during 
the replication cycle. 
Pritchett and Zee (1975) used a series of sucrose gradients to 
purify 3H-labeled BVDV from 14c-labeled cell proteins. They recovered 
453 of the viral infectivity after purification, but were unsuccessful 
in separating cellular proteins from the viral proteins. Felmingham 
and Brown (1977) recovered 793 of the viral infectivity using ammonium 
sulphate precipitation, Tween-80, and sucrose gradient purification 
procedures. They found labeled cellular proteins banding in similar 
locations as the labeled BVD viral proteins after isopycnic-zonal cen-
trifugation. Moreno-Lopez et al. (1981) reported that purification 
methods utilizing the Cj lectin also resulted in the co-purification of· 
cellular proteins with BVD viral proteins. Like many other methods of 
purification, use of the RCA lectin did not effectively remove the cel-
lular proteins. As can be seen in Table 1, a large portion of protein 
from the BT cell control was bound by the RCA lectin. As a result, RCA 
lectin affinity chromatography does not effectively remove cellular pro-
teins during the purification process. 
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Although the RCA lectin was inefficient in removing cellular pro-
teins from the viral preparations, some purification was achieved. With 
isolate 7443, an 80-fold increase in the amount of infectivity relative 
to the quantity of protein present in the eluate was seen over that of 
the stock. This rate of purification compares favorably to that report-
ed by Pritchett and Zee (1975). By using sucrose gradient and isopycnic 
centrifugation, they obtained a 100-fold purification rate. 
Separation and molecular weight determination of the polypeptides 
which compose BVDV were attempted by means of HPgPC in both a nondenatur-
ing and a denaturing system. Neither system resulted in the separation 
or identification of polypeptides which could distinguish between iso-
lates and/or the BT cell control. Preparations of isolates Singer, NADL, 
NY-1, and 7443, and the BT cell control did not separate into smaller 
peaks under nondenaturing HPgPC (Figure 2). Peaks with similar molecu-
lar weights, greater than 440 kd, were seen for the 4 isolates and BT 
cell control. Significance of the secondary peak seen for isolates NADL, 
7443, and NY-1 can not be determined since the BT cell control may also 
possess this peak. Upon denaturing, several smaller polypeptides were 
separated for each BVD isolate and the BT cell control (Figure 3). 
Peaks seen for each isolate and the BT cell control co-migrated, again 
making resolution between the isolates and the BT cell control impos-
sible. A large secondary peak is present for the 4 isolates and BT cell 
control, emerging considerably later than the 12.5 kd marker. This peak 
most likely results from use of 2-mercaptoethanol in the denaturing proc-
ess (Montelaro et al. 1981). 
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Failure to demonstrate distinct differences within these samples in 
both the native and denatured modes was due in part to the quantity of 
cellular proteins which co-purified with the BVO isolates on the RCA 
lectin. Incomplete resolution of the separated peaks in the denatured 
chromatographs may be attributed to the fact that molecular weight ra-
tios of the separated peaks were smaller than the minimum molecular 
weight ratio (Rm) of 2 required for complete resolution by the TSK 3000 
SW column (Pfannkoch et al. 1980). Another factor to be considered in 
the failure to obtain distinctions within the isolates is incomplete de-
naturation of the viral polypeptides prior to chromatographing. 
Continuous SOS-PAGE of the isolates Singer, NADL, 7443, and NY-1 
resulted in the separation of polypeptides which demonstrated distinct 
differences between the isolates, especially between the cytopathic and 
noncytopathic isolates. However, SOS-PAGE of the BT cell control re-
sulted in several polypeptides with estimated molecular weights similar 
to those of the other isolates, making identification of the polypep-
tides of viral origin impossible (Figure 3). 
In an effort to make this identification, discontinuous SOS-PAGE 
and electrophoretic transfer of separated polypeptides to nitrocellulose 
(Western blotting) with subsequent labeling staining of the discontin-
uous SOS electrophoretic gel prior to blotting revealed slight varia-
tions in the molecular weights and numbers of polypeptides composing 
each isolate. The BT cell control contained polypeptides of similar 
molecular weights to those of isolates Singer, NADL, TGAC, 7443, NY-1, 
and Tifton (Figure 4). 
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To maintain antigenic integrity of the viral polypeptides in the 
Western blots, modifications to the standard methods of Laemmli (1970) 
for SDS-PAGE and Towbin et al. (1979) for Western blotting were required. 
In SDS-PAGE, 2-mercaptoethanol was omitted from the sample buffer. Prior 
to electrophoretic transfer of the separated polypeptides from the elec-
trophoretic gel to nitrocellulose, renaturation of the polypeptides was 
necessary. Soaking the gel in the renaturation buffer containing 4M 
urea removes SDS, allowing the polypeptides to assume a configuration 
closer to that of the native polypeptide. 
Detection of the bound specific immunoglobulin was done with Pro-
tein A. Two Protein A systems were used, BPA followed by HRP-SA and 
125IPA. Low levels of reactivity were detected with the BPA/HRP-SA 
system. h f d . h ' h 125 A . d ... T e use o autora iograp y wit IP increase sensitivity. 
Anti-BVDV immunoglobulin labeled two protein bands on each of the 
viral nitrocellulose replicas, while a single protein band was labeled 
on the BT cell control. These labeled protein bands had molecular 
weights of greater than 200 kd, with the molecular weight of the viral 
specific protein band being smaller than the nonspecific band. When the 
nitrocellulose replicas were labeled with anti-BT immunoglobulin, a pro-
tein band of greater than 200 kd was.identified in the viral and the BT 
cell control replicas. Immunoglobulin from a normal calf did not identi-
fy any protein band. 
Anti-BVDV immunoglobulin labeled a protein band on the BT cell con-
trol which corresponds to one of the protein bands seen on the viral 
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replicas. A protein band of greater than 200 kd also was labeled by 
anti-BT immunoglobulin on the viral and BT cell control replicas. These 
proteins are most likely of cell origin. Antibodies to these cellular 
antigens in the anti-BVDV and anti-BT immunoglobulins are due to the 
presences of cellular protein complexes in the immunizing preparations 
due to viral induced and mechanically induced lysis of BT cells. The 
total lack of reactivity seen with the normal calf immunoglobulin indi-
cates that this is an induced immune response following exposure to BT 
cell debris. 
The virus-specific protein bands retained their antigenicity, but 
were incompletely dissociated. Specific polypeptides were not identi-
fied. Failure to identify individual polypeptides may be the result of 
the methodology. The successful electrophoretic transfer of the smaller 
polypeptides took place since all of the molecular weight markers could 
be identified on the nitrocellulose replica. Antigenicity of the smal-
ler denatured polypeptides was not restored by the renaturing buffer. 
Akkina (1982) successfully immunoprecipitated 1% NP40, 0.5% deoxycholate, 
and 1% trasylol dissociated BVD viral polypeptides from cell lysates; 
however, this step occurred prior to the solubilizing step required in 
SDS-PAGE. In contrast, in this study dissociation, denaturation, and 
solubilization of the viral polypeptides for SDS-PAGE occurred in the 
same step. Consequently, failure to restore antigenicity to the sepa-
rated polypeptides could be due to incomplete removal of the SDS in the 
renaturation step concealing the haptens, inability of the polypeptides 
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to regain their original antigenicity, or complete denaturation result-
ing in polypeptides which have lost the specificity of the whole virion. 
Earlier studies of the molecular weights of the structural poly-
peptides of BVDV made use of radiolabeling. Pritchett and Zee (1975) 
labeled cellular proteins with 14c and viral proteins with 3H leucine. 
After electrophoresis, location of the radiolabeled products was deter-
mined, and origins of the polypeptides could be distinguished by the 
type of label present. A large amount of 14c radiolabeled cellular pro-
tein co-migrated during electrophoresis with 3H radiolabeled virus. 
Matthaeus (1979), Akkina (1982), and Purchio et al. (1984a) immunopre-
cipitated 
35s methionine labeled BVDV from cell cultures thus eliminat-
ing most of the cellular polypeptides. Although, BVDV is not easily 
radiolabeled, these methods may prove to be the most beneficial in 
future studies of BVDV. 
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CONCLUSION 
Affinity chromatography with the RCA lectin was able to achieve a 
purification rate for BVDV which is comparable to other purification 
methods. The lectin purified virus retained its infectivity, although 
in some instances at moderately reduced levels. Only one of the 6 iso-
lates purified with this method demonstrated a purification rate similar 
to the 100-fold purification rate reported by Pritchett and Zee (1975). 
Factors contributing to the low purification rates of the other 
viral isolates can only be surmised. These factors may include cyto-
pathogenicity of the isolate, level of infectivity present in the ini-
tial virus stock, and length of time the viral concentrates were exposed 
to PEG-20 during hydroextraction. 
Identification of the structural polypeptides composing the BVD 
virion and their respective molecular weights could not be determined by 
HPgPC, continuous SDS-PAGE or discontinuous SDS-PAGE. A common diffi-
culty in using these methods which could not be overcome was the failure 
to identify whether the separated polypeptides were of viral or cellular 
origin. This inability to identify the source of the polypeptides is 
associated with the affinity of the RCA lectin for galactosyl residues 
present on both the viral polypeptides and cellular polypeptides. 
It had been hoped that subsequent use of Western blots and labeling 
of the electrophoretically separated polypeptides with specific immuno-
globulin would overcome this problem. Akkina (1982) had successfully 
immunoprecipitated the dissociated polypeptides of BVDV prior to SDS-
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PAGE. Since these dissociated polypeptides maintained their antigenic-
ity, it was presumed that polypeptides resulting from dissociation, de-
naturation and solubilization of whole BVDV prior to SDS-PAGE would also 
be antigenic. During electrophoresis and Western blotting, these poly-
peptides had lost their antigenicity. In order to restore antigenicity 
to these polypeptides on the nitrocellulose replicas, the electrophor-
etic gels were soaked in a renaturing buffer prior to Western blotting. 
I 
This renaturing step restored antigenicity to the large protein aggre-
gates but not the small polypeptides. 
Other renaturing buffers have been formulated (Bers and Garfin 
1985). Use of one of these could result in renaturation of the solu-
bilized and denatured viral polypeptides, allowing for the identifica-
tion of these polypeptides on the nitrocellulose replicas as of viral 
origin. This in turn would allow similar studies to be conducted in 
which radiolabeling would not be required for determining molecular 
weights of the structural polypeptides of BVDV. 
A large proportion of the viral and BT cell control proteins de-
posited on the nitrocellulose replicas were not completely denatured 
prior to electrophoresis. Both anti-BVDV and anti-BT immunoglobulins 
identified a large band on the nitrocellulose replica with the same 
electrophoretic mobility. This protein aggregate may be cellular pro-
teins which co-purified with the isolates. 
Due to the inability of the RCA lectin to adequately remove the 
cellular proteins from the viral preparations, separation techniques 
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such as HPgPC, continuous SDS-PAGE, and discontinuous SDS-PAGE could not 
be used to successfully identify the viral polypeptides. These tech-
niques may be useful in the identification of viral polypeptides only 
if a viral preparation can be obtained free of host cell protein. 
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